Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Adaptive Biotechnologies Corp (ADPT) – Adaptive Biotechnologies Corp Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ADPT trades at $12.96, up 1.97% today, with a bearish technical signal but improving fundamentals. Revenue grew to $277M in 2025, and net losses narrowed to -$59M. The company has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $20.20 price target, though insider selling and negative cash flow from operations present headwinds.
The outlook hinges on sustained revenue growth and path to profitability. Investment opportunity lies in the 56% upside to consensus target, but risks include persistent losses, high valuation multiples, and significant insider selling. Positive earnings surprises and cash flow improvement are key catalysts for investor confidence.
Read full analysis

Key Stats

  • Market Cap
    $2.23B
  • Sector
    Health
  • 3M Drawdown
    -24.61%
  • Enterprise Value
    $2.09B
  • Dividend Yield
    -
  • Typical Hold Time
    34 days
$13.94
52W Low: $8.84
22 May 2025
52W High: $20.46
24 Nov 2025

Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $2.23B, with an enterprise value of $2.09B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $8.84 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -24.61%, reflecting recent price volatility. On average, investors hold Adaptive Biotechnologies Corp for approximately 34 days, indicating typical investor behavior on the platform.

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $2.23B
  • Sector
    Health
  • 3M Drawdown
    -24.61%
  • Enterprise Value
    $2.09B
  • Dividend Yield
    -
  • Typical Hold Time
    34 days
$13.94
52W Low: $8.84
22 May 2025
52W High: $20.46
24 Nov 2025

Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $2.23B, with an enterprise value of $2.09B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $8.84 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -24.61%, reflecting recent price volatility. On average, investors hold Adaptive Biotechnologies Corp for approximately 34 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!